Inhaled medications are the mainstay of pharmacological treatment for people with chronic obstructive pulmonary disease and asthma. This second article in a two-part series describes the procedure for ...

Switching asthma patients from a pressurised metered dose inhaler (pMDI) to a dry powder inhaler (DPI) for maintenance therapy more than halves their carbon footprint without loss of asthma control, ...

Researchers in the United Kingdom compared the potential impact on carbon footprint and asthma symptom control of switching maintenance therapy to a dry powder inhaler vs continuing with a metered ...